Patents by Inventor Claude Moutonnier

Claude Moutonnier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4365062
    Abstract: New cephalosporins of the formula: ##STR1## in which n=0 or 1, R.sub.1 is a radical of the formula: ##STR2## [in which R.sub.4 is a protective radical and R.sub.5 is hydrogen, alkyl, vinyl, cyanomethyl or a protective radical], or R.sub.1 is a protective radical and R.sub.2 is a protective radical or an enzymatically removable radical, or R.sub.1 is an acyl radical which may be substituted in various ways and R.sub.2 is a protective radical, in the 3-oxoethyl-bicyclooct-2-ene or -bicyclooct-3-ene or 3-oxoethylidene-bicyclooctane form if n=0, and in the 3-oxoethyl-bicyclooct-2-ene or 3-oxoethylidene-bicyclooctane form if n=1, are useful as intermediates for the preparation of 3-thiovinyl-cephalosporins useful as antibacterial agents.
    Type: Grant
    Filed: May 21, 1980
    Date of Patent: December 21, 1982
    Assignee: Rhone-Poulenc Industries
    Inventors: Daniel Farge, Claude Moutonnier, Pierre Le Roy, Jean-Francois Peyronel
  • Patent number: 4347359
    Abstract: New thiols of the general formula: ##STR1## wherein A represents a 2-hydroxy-1-oxoethan-1-yl-2-ylidene or alkoxycarbonylmethyne radical or a nitrogen atom and R represents various substituted alkyl radicals, and their alkali metal and alkaline earth metal salts are useful as intermediates in the preparation of cephalosporins having anti-bacterial properties.
    Type: Grant
    Filed: January 15, 1981
    Date of Patent: August 31, 1982
    Assignee: Rhone-Poulenc Industries
    Inventors: Daniel Farge, Pierre Le Roy, Claude Moutonnier, Jean-Francois Peyronel
  • Patent number: 4307230
    Abstract: Novel 3-vinyl-cephalosporins of the formula ##STR1## in which n is 0 or 1, R.sub.1 is hydrogen, a radical of the formula ##STR2## [in which R.sub.4 is hydrogen or a protective radical and R.sub.5 is hydrogen, alkyl, vinyl or cyanomethyl or is a protective radical], or a protective radical, and R.sub.2 is hydrogen, a protective radical or an enzymatically removable radical, or R.sub.1 is hydrogen or an acyl radical which may carry various substituents and R.sub.2 is hydrogen or a protective radical, and R.sub.3 is a radical of the general formula R'.sub.3 --SO.sub.2 --O-- or R".sub.3 --CO--O--, in which R'.sub.3 is alkyl, trifluoromethyl, trichloromethyl or phenyl which is substituted by a halogen atom or by an alkyl or nitro radical, and R".sub.3 is defined like R'.sub.3 or represents methyl which is substituted by acyl or alkoxycarbonyl, or represents ethyl or propyl substituted in the 2-position by acyl or alkoxycarbonyl.
    Type: Grant
    Filed: May 21, 1980
    Date of Patent: December 22, 1981
    Assignee: Rhone-Poulenc Industries
    Inventors: Daniel Farge, Claude Moutonnier, Pierre Le Roy, Jean-Francois Peyronel
  • Patent number: 4307116
    Abstract: Novel cephalosporins of the general formula (I); ##STR1## in which R is alkyl, L-2-amino-2-carboxy-ethyl, phenyl, pyridyl, pyridyl-N-oxide, pyrimidin-2-yl, substituted pyridazin-3-yl, 5,6-dioxo-1,4,5,6-tetrahydro-1,2,4-triazin-3-yl substituted in the 4-position, 1,3,4-triazol-5-yl or 2-alkoxycarbonyl-1,3,4-triazol-5-yl substituted in the 1-position, 1,4-dialkyl-5,6-dioxo-1,4,5,6-tetrahydro-1,2,4-triazin-3-yl, 1-alkyl-5,6-dioxo-1,4,5,6-tetrahydro-1,2,4-triazin-3-yl, 2-alkyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl, triazol-5-yl, 1,3,4-thiadiazol-5-yl which is substituted or unsubstituted, 1,2,4-thiadiazol-5-yl which is substituted, 1,3,4-oxadiazol-5-yl which is substituted or unsubstituted, oxazol-2-yl which is substituted or unsubstituted or tetrazol-5-yl which is substituted or unsubstituted in the 1-position, R' is a hydrogen atom or a radical of the general formula (II); ##STR2## and R.sup.o is hydrogen, alkyl, vinyl or cyanomethyl, as well as their salts, are useful as anti-bacterial agents.
    Type: Grant
    Filed: May 21, 1980
    Date of Patent: December 22, 1981
    Assignee: Rhone-Poulenc Industries
    Inventors: Daniel Farge, Claude Moutonnier, Pierre Le Roy, Jean-Francois Peyronel
  • Patent number: 4307233
    Abstract: Novel 3-vinyl-cephalosporin derivates of the general formula ##STR1## in the bicyclooct-2-ene or bicyclooct-3-ene form, in which R.sub.1 is a protective radical or is a radical of the general formula ##STR2## in which R.sub.5 is hydrogen, alkyl, vinyl or cyanomethyl, or a protective radical, and R.sub.6 is hydrogen or a protective radical, and R.sub.2 is a protective radical or an enzymatically removable radical, or R.sub.1 is an acyl radical, which may carry various substituents, and R.sub.2 represents a protective radical, and R.sub.3 and R.sub.4, which are identical or different, represent alkyl (optionally substituted by hydroxyl, alkoxy, amino, alkylamino or dialkylamino) or phenyl, or form, together with the nitrogen atom, a saturated 5-membered or 6-membered heterocyclic ring optionally containing another hetero-atom, their E- and Z-forms and their mixtures, are useful as intermediates for the preparation of 3-thiovinyl cephalosporins useful as antibacterial agents.
    Type: Grant
    Filed: May 21, 1980
    Date of Patent: December 22, 1981
    Assignee: Rhone-Poulenc Industries
    Inventors: Daniel Farge, Claude Moutonnier, Pierre Le Roy, Jean-Francois Peyronel
  • Patent number: 4291032
    Abstract: New thiazolo[3,2-c]-1,3-benzoxazine derivatives of the general formula (I), in which X is oxygen or sulfur, R.sub.1 and R.sub.2, which are identical or different, are hydrogen or halogen atoms or alkyl, alkoxy, alkylthio or trifluoromethyl radicals, in the 7-, 8-, 9- or 10-position, and R.sub.3 is a hydrogen atom or a carboxyl radical, their salts, if appropriate, their preparation and the medicaments in which they are present.These new derivatives are particularly useful as analgesic agents.
    Type: Grant
    Filed: October 2, 1980
    Date of Patent: September 22, 1981
    Assignee: Rhone Poulenc Industries
    Inventors: Christian Berger, Daniel Farge, Claude Moutonnier, Gerard Wolff
  • Patent number: 4178290
    Abstract: .alpha.-Amino(1,3-dithiin-5-yl)-acetic acid in the D-, L-, or D,L-form and in which the amino radical is free or protected by tert.-butoxycarbonyl or 2,2,2-trichloroethoxycarbonyl is a useful intermediate in the preparation of cephalosporins having valuable antibacterial activity.
    Type: Grant
    Filed: June 6, 1978
    Date of Patent: December 11, 1979
    Assignee: Rhone-Poulenc Industries
    Inventors: Christian Berger, Dominique Deprez, Daniel Farge, Claude Moutonnier, Gerard Wolff
  • Patent number: 4088761
    Abstract: The invention provides novel cephalosporins of the formula: ##STR1## in which R.sub.1 represents acetoxy, (5-methyl-1,3,4-thiadiazol-2-yl)-thio, (1-methyl-tetrazol-5-yl)-thio or [1-(2-hydroxyethyl)-tetrazol-5-yl]-thio and R.sub.2 represents carboxyl, or R.sub.1 represents pyridinio and R.sub.2 the carboxylato ion, and, when R.sub.2 represents carboxyl, their metal salts and addition salts with nitrogen-containing bases, which have useful antibacterial properties.
    Type: Grant
    Filed: January 17, 1977
    Date of Patent: May 9, 1978
    Assignee: Rhone-Poulenc Industries
    Inventors: Christian Berger, Daniel Farge, Claude Moutonnier
  • Patent number: 4071531
    Abstract: New oxathiino- and dithiino-aminoacetic acids of the formula: ##STR1## in which A represents oxygen or sulphur, together with their racemic forms, their optically active forms and mixtures thereof, their reactive derivatives and their acid addition salts, are valuable intermediates for the preparation of therapeutically active derivatives, in particular cephalosporin derivatives of the formula: ##STR2## where R is hydrogen or acetoxy.
    Type: Grant
    Filed: September 26, 1975
    Date of Patent: January 31, 1978
    Assignee: Rhone-Poulenc Industries
    Inventors: Christian Berger, Daniel Farge, Georges Gros, Mayer Naoum Messer, Claude Moutonnier
  • Patent number: 4034090
    Abstract: New cephalosporin derivatives of the formula: ##STR1## in which either (a) R.sub.1 is hydrogen, acetoxy, azido or heterocyclylthio or heterocyclylcarbonylthio which is (1,3,4-thiadiazol-2-yl)-thio which is unsubstituted or substituted by straight or branched chain C.sub.1-4 alkyl or alkoxy, straight or branched chain C.sub.1-4 alkylthio, straight or branched chain C.sub.1-4 alkylsulphonyl, amino or acetylamino; (1,2,3,4-tetrazol-5-yl)-thio which is unsubstituted or substituted in the 1-position by straight or branched chain C.sub.1-4 alkyl, hydroxy straight or branched chain C.sub.1-4 alkyl, phenyl or hydroxyphenyl, or in the 2-position by straight or branched chain C.sub.1-4 alkyl or hydroxy straight or branched chain C.sub.1-4 alkyl; (1,2,4-triazol-3-yl)-thio, (4-methyl-1,3-thiazol-2-yl)-thio, (3-methyl-1,2,4-thiadiazol-5-yl)-thio or (1,2,3-thiadiazol-4-yl)-carbonylthio, and R.sub.
    Type: Grant
    Filed: June 30, 1975
    Date of Patent: July 5, 1977
    Assignee: Rhone-Poulenc Industries
    Inventors: Christian Berger, Daniel Farge, Georges Gros, Mayer Naoum Messer, Claude Moutonnier
  • Patent number: 4034088
    Abstract: New cephalosporin derivatives of the general formula: ##STR1## in which R represents a straight or branched chain C.sub.1-4 alkyl radical, or a phenyl (straight or branched chain C.sub.1-4 alkyl) radical, n is 0, 1 or 2, and either R.sub.1 is a pyridinio ion and R.sub.2 is a carboxylato ion, or R.sub.1 represents a hydrogen atom, or an acetoxy, (5-methyl-1,3,4-thiadiazol-2-yl)-thio or (1-methyl-1,2,3,4-tetrazol-5-yl)-thio radical and R.sub.2 represents a carboxy radical or a radical of the formula; ##STR2## in which the radical: ##STR3## is a radical which can be removed easily by enzymatic means and in which R.sub.3 represents a hydrogen atom or a straight or branched chain C.sub.1-4 alkyl radical, a phenyl radical or a phenyl (C.sub.1-2 alkyl) radical and R.sub.4 represents a straight or branched chain C.sub.1-4 alkyl radical, a straight or branched chain C.sub.1-4 alkoxy radical, a cyclohexyl radical, a phenyl radical or a phenyl (C.sub.
    Type: Grant
    Filed: April 30, 1975
    Date of Patent: July 5, 1977
    Assignee: Rhone-Poulenc Industries
    Inventors: Christian Berger, Daniel Farge, Georges Gros, Mayer Naoum Messer, Claude Moutonnier
  • Patent number: 4029781
    Abstract: New cephalosporin compounds of the formula: ##STR1## in which A is oxygen or sulphur, R.sub.1 is hydrogen or acetoxy and R.sub.2 is carboxy or a radical of the formula: ##STR2## in which the radical ##STR3## is a radical which can be easily removed enzymatically, and in which R.sub.3 is hydrogen or straight or branched chain C.sub.1-4 alkyl and R.sub.4 is straight or branched chain C.sub.1-4, alkyl or cyclohexyl, together with its diastereoisomeric forms and mixtures thereof, its acid addition salts and, where appropriate, its pharmaceutically acceptable non-toxic metal salts and addition salts with nitrogen-containing bases other than ammonia, exhibit valuable anti-bacterial properties, in particular against Gram-positive and Gram-negative bacteria.
    Type: Grant
    Filed: September 26, 1975
    Date of Patent: June 14, 1977
    Assignee: Rhone-Poulenc Industries
    Inventors: Christian Berger, Daniel Farge, Georges Gros, Mayer Naoum Messer, Claude Moutonnier
  • Patent number: 4007176
    Abstract: New cephalosporin derivatives of the formula: ##STR1## wherein one of A and A.sub.1 represents oxygen or sulphur and the other represents sulphur, R.sub.1 represents hydrogen, acetoxy, (5-methyl-1,3,4-thiadiazol-2-yl)thio or (1-methyl-1,2,3,4-tetrazol-5-yl)thio and R.sub.2 represents carboxy, or R.sub.1 represents a pyridinio radical and R.sub.2 represents the carboxylate ion, are therapeutically useful compounds possessing antibacterial properties.
    Type: Grant
    Filed: November 12, 1974
    Date of Patent: February 8, 1977
    Assignee: Rhone-Poulenec S.A.
    Inventors: Christian Berger, Daniel Farge, Georges Gros, Mayer Naoum Messer, Claude Moutonnier